Foreword by John Barrett vii
Foreword by Stephanie J Lee viii
Foreword by John Goldman ix
List of Contributors x
Section 1 Late effects concepts 1
1 Introduction 3
Bipin N Savani
2 Overview: transplant data and increasing numbers of long-term survivors 7
Jakob R Passweg and Helen Baldomero
3 Long-term transplant clinic setup 11
André Tichelli, Joerg P Halter, Jakob R Passweg, and Alicia Rovó
4 Late effects after allogeneic hematopoietic stem cell transplantation 21
Shahrukh Hashmi and Mark R Litzow
5 Late effects after autologous hematopoietic stem cell transplantation 31
Sairah Ahmed and Yago Nieto
6 Graft-versus-host disease and late effects after hematopoetic stem cell transplantation 43
Gérard Socié
7 Prominent role of allied health professionals (nurse practitioners, physician assistants, others) in long-term follow-up after hematopoietic stem cell transplantation 52
Catherine E Lucid
Section 2 Management, 55
8 Screening and prevention guidelines for hematopoietic cell transplant survivors 57
Navneet S Majhail and J Douglas Rizzo
9 Secondary malignancies: prevalence, screening, prevention, and management guidelines 65
Paolo F Caimi and Hillard M Lazarus
10 Cutaneous chronic graft-versus-host disease 77
Attilio Olivieri, Daniela Massi, Andrea Bacigalupo, and Anna Campanati
11 Anti-infective prophylaxis, immunization and prevention of recurrent infectious complications in long-term survivors 106
John P Galvin and Jayesh Mehta
12 Seasonal virus infections: prevention and management guidelines 116
Gaurav Trikha and John R Wingard
13 Exposure to family members: infections and recent live vaccinations 130
Brian G Engelhardt and James E Crowe, Jr
14 Late pulmonary complications after allogeneic hematopietic stem cell transplantion: bronchiolitis
obliterans syndrome (BOS) and organizing pneumonia (OP) 141
Lee Gazourian, Gerald L Weinhouse, Joseph H Antin, and Vincent T Ho
15 Post-transplantation bone disease: prevalence, monitoring, prevention, and management guidelines 151
Kathryn Dahir, Brandon Perry, and Shubhada Jagasia
16 Ocular complications: prevalence, monitoring, prevention, and management guidelines 162
André Tichelli and Alicia Rovó
17 Oral complications in hematopoietic stem cell transplantation survivorship 172
Sharon Elad, Corey Cutler, and Nathaniel Treister
18 Sexual dysfunction in long-term survivors: monitoring and management 183
Andrea L Utz and Shubhada Jagasia
19 Fertility issues, contraception, and pregnancy outcome in long-term survivors 193
Alicia Rovó, Nina Salooja, Carl P Schwarze, Joerg P Halter, and André Tichelli
20 Follow-up of children after hematopoietic stem cell transplantation: growth and development 203
Kristina K Hardy, David A Jacobsohn, and Evelio Perez-Albuerne
21 Posttransplant diabetes mellitus: monitoring, prevention, and management guidelines 215
Prathima Jasti, Shichun Bao, and Shubhada Jagasia
22 Thyroid disease: monitoring and management guidelines 225
M Kathleen Figaro, Cheryl A Fassler, Shubhada Jagasia, and Vipul T Lakhani
23 Special issues related to female long-term survivors 233
Melissa A Merideth, Kristin Clay Chabarria, Tajana Klepac Pulanic, and Pamela Stratton
24 Cardiac and vascular complications in long-term survivors after hematopoietic stem cell transplantation 244
Alicia Rovó and André Tichelli
25 Hyperlipidemia: prevalence, monitoring, management, interactions with immunosuppressive agents, and follow-up 258
Dara L Eckerle Mize, Shubhada Jagasia, and Jeffrey B Boord
26 Hypertension management in long-term survivors 269
Imad Abboud
27 Gastrointestinal complications of hematopoietic cell transplantation 276
Preet Bagi, Niharika Samala, Steven Pavletic, and Theo Heller
28 Hepatic complications of hematopoietic stem cell transplantation 286
Niharika Samala, Preet Bagi, Theo Heller, and Steven Pavletic
29 Monitoring and management of hepatitis B, hepatitis C, and HIV infection before and after transplantation 294
Keith Luckett and Stephen Dummer
30 Prevention and management of renal complications in long-term survivors 304
Michael Dickenmann and Joerg P Halter
31 Immunosuppressive agents and monitoring in long-term survivors 314
Paul Shaughnessy and Helen Leather
Section 3 Supportive care for long-term survivors after HSCT 321
32 Nutritional assessments and nutritional supplementation for long-term transplant survivors: multivitamins, vitamin D, calcium, antioxidants, and minerals 323
Lauren Zatarain, LaQuisa Hill, Daniel R Thomas, and Stacey A Goodman
33 Daily routines and guidelines: driving, infection isolation, masks, food/diet, activities, exercise, pets, sun exposures, and others 332
Angela M Woods
34 Caregivers of long-term survivors 340
Elizabeth Wulff-Burchfield
35 Health-related quality of life in adult and pediatric survivors of hematopoietic stem cell transplantation 345
Margaret Bevans and Lori Wiener
36 Prevalent psychosocial adjustment issues and solutions: lifestyle and social challenges 368
Katrina M Stokes
37 A patient’s perspective: concepts of long-term survivor support groups and their roles 376
Michael W Brown
APPENDIX 1 NMDP/Be The Match posttransplant guidelines resources 379
Darlene Haven
APPENDIX 2 Long-term follow-up calendar 381
André Tichelli, Joerg P Halter, Jakob R Passweg, and Alicia Rovó
APPENDIX 3 Commonly used transplant-related medications in long-term survivors 385
Melissa Logue
Index, 387